Aśka (Joanna) Przewrocka
Wellcome Trust Centre for Human Genetics, Roosevelt Dr.
My project involves identification of rare genetic variants that cause 5-FU and bevacizumab toxicity, as well as health economic evaluation of current approaches in stratified cancer diagnosis.
Koelsch C, Przewrocka J, Keeling P. (2013). Towards a balanced value business model for personalized medicine: an outlook. Pharmacogenomics 14(1):89-102. doi: 10.2217/pgs.12.192.